INTERLABORATORY COMPARISON OF TOTAL CYTOCHROME-P-450 AND PROTEIN DETERMINATIONS IN RAT-LIVER MICROSOMES - REINVESTIGATION OF ASSAY CONDITIONS

被引：204
作者：
RUTTEN, AAJJL
FALKE, HE
CATSBURG, JF
TOPP, R
BLAAUBOER, BJ
VANHOLSTEIJN, I
DOORN, L
VANLEEUWEN, EXR
机构：
[1] AGR UNIV WAGENINGEN,DEPT TOXICOL,6703 BC WAGENINGEN,NETHERLANDS
[2] STATE UNIV UTRECHT,DEPT VET PHARM PHARMACOL & TOXICOL,3508 TD UTRECHT,NETHERLANDS
[3] NATL INST PUBL HLTH & ENVIRONM HYG,TOXICOL LAB,3720 BA BILTHOVEN,NETHERLANDS
来源：
ARCHIVES OF TOXICOLOGY | 1987年 / 61卷 / 01期
关键词：
D O I：
10.1007/BF00324544
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：27 / 33
页数：7
相关论文
共 10 条
[1]   PRESERVATION OF RAT HEPATIC MICROSOMAL-ENZYME ACTIVITIES - EFFECT OF LOW-TEMPERATURE AND FREEZE-DRYING [J].
BARTOSEK, I ;
DOLFINI, E ;
GHERSA, P ;
GUAITANI, A ;
VILLA, P ;
VILLA, S .
JOURNAL OF PHARMACOLOGICAL METHODS, 1980, 3 (03) :191-200
[2]   STABILITY OF RAT LUNG AND LIVER MICROSOMAL CYTOCHROME-P-450 ENZYME-ACTIVITIES TO STORAGE - PURIFIED MICROSOMAL FRACTION, POSTMITOCHONDRIAL FRACTION, AND WHOLE TISSUE [J].
DANNERRABOVSKY, J ;
GROSECLOSE, RD .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1982, 10 (4-5) :601-611
[3]   STABILITY OF ACTIVATING SYSTEMS FOR INVITRO MUTAGENESIS ASSAYS - ENZYME-ACTIVITY AND ACTIVATING ABILITY FOLLOWING LONG-TERM STORAGE AT -85-DEGREES-C [J].
DENT, JG ;
SCHNELL, S ;
GRAICHEN, ME ;
ALLEN, P ;
ABERNETHY, D ;
COUCH, DB .
ENVIRONMENTAL MUTAGENESIS, 1981, 3 (02) :167-179
[4]  
HAYES AW, 1982, PRINCIPLES METHODS T, P611
[5]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[6]   QUANTITATIVE-DETERMINATION OF CYTOCHROME-P-450 IN RAT-LIVER HOMOGENATE [J].
MATSUBARA, T ;
KOIKE, M ;
TOUCHI, A ;
TOCHINO, Y ;
SUGENO, K .
ANALYTICAL BIOCHEMISTRY, 1976, 75 (02) :596-603
[7]  
OMURA T, 1964, J BIOL CHEM, V239, P2379
[8]  
OMURA T, 1964, J BIOL CHEM, V239, P2370
[9]  
PEARSON K, 1981, BIOMETRY, P565
[10]   DETERMINATION OF DRUG-METABOLIZING ENZYMES IN NEEDLE BIOPSIES OF HUMAN LIVER [J].
SCHOENE, B ;
OLDERSHA.HF ;
FLEISCHMANN, RA ;
REMMER, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 4 (02) :65-+
1